ARENA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARENA PHARMACEUTICALS INC has filed 1,425 SEC EDGAR filings since 28 Apr 2000

SEC filing history

Showing 701-725 of 822 matching filings.

Per page
25
Current page
29
3

PRIMARY DOCUMENT

Filing date
29 Aug 2011
Reporting date
29 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
12 Aug 2011
Reporting date
12 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
11 Aug 2011
Reporting date
09 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
09 Aug 2011
Reporting date
09 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
02 Aug 2011
Reporting date
02 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
13 Jul 2011
Reporting date
12 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
24 Jun 2011
Reporting date
24 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
26 May 2011
Reporting date
26 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-31161

FORM 10-Q

Filing date
10 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
10 May 2011
Reporting date
10 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-31161

AUTO-GENERATED PAPER DOCUMENT

Filing date
28 Apr 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-31161

DEFINITIVE PROXY STATEMENT

Filing date
27 Apr 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-167498

PROSPECTUS

Filing date
25 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

FORM 8-K

Filing date
29 Mar 2011
Reporting date
28 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-166481

RULE 424(B)(5)

Filing date
29 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-166481

ISSUER FREE WRITING PROSPECTUS

Filing date
29 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .